323 related articles for article (PubMed ID: 3937250)
21. Comparison of plasminogen activators.
Robbins KC; Barlow GH; Nguyen G; Samama MM
Semin Thromb Hemost; 1987 Apr; 13(2):131-8. PubMed ID: 3114881
[No Abstract] [Full Text] [Related]
22. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
Sprengers ED; Akkerman JW; Jansen BG
Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
[TBL] [Abstract][Full Text] [Related]
23. Effect of caffein ingestion on plasma fibrinolytic potential.
Wojta J; Kirchheimer JC; Peska MG; Binder BR
Thromb Haemost; 1988 Apr; 59(2):337-8. PubMed ID: 3133816
[No Abstract] [Full Text] [Related]
24. Human articular cartilage contains an inhibitor of plasminogen activator.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of thrombolytic enzymes].
Matsuo O
Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
Christensen U; Holmberg L; Bladh B; Astedt B
Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
[TBL] [Abstract][Full Text] [Related]
27. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
28. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
29. Advances in clinical fibrinolysis.
Hessel LW; Kluft C
Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
[TBL] [Abstract][Full Text] [Related]
30. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
[TBL] [Abstract][Full Text] [Related]
31. Amiloride selectively inhibits the urokinase-type plasminogen activator.
Vassalli JD; Belin D
FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
[TBL] [Abstract][Full Text] [Related]
32. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
[TBL] [Abstract][Full Text] [Related]
33. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
Hayashi T
Rinsho Byori; 1994 Apr; 42(4):346-51. PubMed ID: 8176842
[TBL] [Abstract][Full Text] [Related]
34. [Plasminogen activators in tumor tissue].
Tomasiuk R; Mirowski M; Wierzbicki R
Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
[No Abstract] [Full Text] [Related]
35. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
Clemmensen I; Thorsen S; Müllertz S
Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
[TBL] [Abstract][Full Text] [Related]
36. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
[TBL] [Abstract][Full Text] [Related]
37. [Plasminogen tissue activator and plasminogen tissue inhibitor in type II diabetes].
Rość D; Drewniak W; Kotschy M; Graczykowska-Koczorowska A; Raukuć D
Pol Merkur Lekarski; 1997 Jan; 2(7):24-5. PubMed ID: 9296893
[TBL] [Abstract][Full Text] [Related]
38. Human plasminogen activators. Genes and proteins structure.
Blasi F; Riccio A; Sebastio G
Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360
[No Abstract] [Full Text] [Related]
39. Isolation of peptides with anti-urokinase activity from the human placenta.
Uszynski M
Thromb Haemost; 1980 Feb; 42(5):1411-6. PubMed ID: 6768150
[TBL] [Abstract][Full Text] [Related]
40. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]